Antibody
AssigneeQueen Mary University of London
InventorsMichele Bombardieri, Constantino Pitzalis, Elisa Corsiero
Life of this patent
Estimating the term…
Abstract
The present invention provides an antibody which comprises a variable heavy (VH) chain comprising CDR1, CDR2 and CDR3, and/or a variable light (VL) chain comprising CDR1, CDR2 and CDR3, wherein the CDRs have the same amino acid sequence as those from a complete antibody isolated from a synovial tissue sample of rheumatoid arthritis patients, as listed in Tables 1 and 2 or Tables 1 A and 2 A.
Claims10
An antibody which comprises a variable heavy (VH) chain comprising CDR1, CDR2 and CDR3, and a variable light (VL) chain comprising CDR1, CDR2 and CDR3, wherein the VH-CDR1 amino acid sequence is GGTFSSYA (SEQ ID NO:
- 106), wherein the VH-CDR2 amino acid sequence is IIPIFGTA (SEQ ID NO:
- 108), wherein the VH-CDR 3 amino acid sequence is VRITIFGVVMVKSDNWFDP (SEQ ID NO:
- 306), wherein the VL-CDR1 amino acid sequence is QSVSSN (SEQ ID NO:
- 549), wherein the VL-CDR2 amino acid sequence is GAS, and wherein the VL-CDR3 amino acid sequence is QQYNNLYT (SEQ ID NO:
- 715);
- wherein the antibody is selected from the group consisting of a recombinant full-length antibody comprising the VH and VL chains from one species and a constant domain from a different species;
- a recombinant functional antibody fragment, wherein the VH chain and VL chain are joined by a polypeptide linker;
- a chimeric antibody;
- a bispecific antibody;
- a minibody;
- and an antibody fusion, wherein the antibody is conjugated to a non-antibody molecule.
Dependencies are inferred from the claim text.